The Second Generation of Cholinesterase Inhibitors: Pharmacological Aspects
- 1 January 1991
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Benzodiazepines, putative anxiolytics and animal models of anxietyTrends in Neurosciences, 1991
- Interactions of 3,4-diaminopyridine and choline in stimulating acetylcholine release and protecting membrane phospholipidsBrain Research, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trialDrug Development Research, 1990
- PREDISPOSING LOCUS FOR ALZHEIMER'S DISEASE ON CHROMOSOME 21The Lancet, 1989
- Presynaptic Markers of Cholinergic Function in Cortex Following Ibotenic Acid Lesion of the Basal ForebrainPublished by Springer Nature ,1989
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- Pharmacokinetics and pharmacodynamics of acetylcholinesterase inhibition: Can acetylcholine levels in the brain be improved in alzheimer's disease?Drug Development Research, 1988
- A comparison of the effects of two inhibitors on brain cholinesteraseNeuropharmacology, 1987
- Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in ratNeurochemical Research, 1986